In vivo efficacy and safety of systemically administered serinol nucleic acid-modified antisense oligonucleotides in mouse kidney.
Tsuboi T, Hattori K, Ishimoto T, Imai K, Doke T, Hagita J, Ariyoshi J, Furuhashi K, Kato N, Ito Y, Kamiya Y, Asanuma H, Maruyama S.
Tsuboi T, et al. Among authors: ishimoto t.
Mol Ther Nucleic Acids. 2024 Dec 18;36(1):102387. doi: 10.1016/j.omtn.2024.102387. eCollection 2025 Mar 11.
Mol Ther Nucleic Acids. 2024.
PMID: 39850319
Free PMC article.